Manufacturer: Actavis
A synthetic and aromatic analog of retinoic acid and the main metabolite of etretinate, which has been used successfully for many years for the treatment of psoriasis and other keratinization disorders. Clinical studies have confirmed that in the case of psoriasis and dyskeratosis, acitretin leads to a normalization of the proliferation, differentiation and keratinization of epidermal cells, at doses where side effects are generally tolerable.